Skip to main content
Triochem Products Ltd. logo

Triochem Products Ltd. — Investor Relations & Filings

Ticker · 512101 ISIN · INE331E01013 BSE.NS Manufacturing
Open in API
Filings indexed 448 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country IN India
Listing BSE.NS 512101

About Triochem Products Ltd.

https://www.triochemproducts.com

Triochem Products Ltd. is a manufacturer and exporter specializing in Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds for the global healthcare and pharmaceutical sectors. Its core product portfolio includes a range of specialized substances such as Quinine salts, Quinidine salts, and other niche therapeutic ingredients. Triochem Products Ltd. emphasizes adherence to stringent quality control measures and international regulatory standards to ensure the efficacy and safety of its chemical outputs. The organization serves a diverse clientele, providing essential raw materials for the formulation of various medications. By leveraging advanced chemical synthesis processes and technical expertise, the company maintains a significant presence in the supply chain for specialized pharmaceutical components.

Recent filings

Filing Released Lang Actions
The Board of Directors have decided that the Register of Members and the Share Transfer Register of the Company shall remain closed from Sunday 16th August 2026 to Saturday 22nd August ....
Regulatory Filings Classification · 85% confidence The document is a notice to the stock exchange under SEBI LODR Regulation 42, informing of book closure/record dates for the upcoming AGM. It contains no financial statements or detailed report content, nor does it announce dividend amounts or management changes. It is a general regulatory compliance announcement (intimation under listing rules). There is no specific category for book‐closure notices, so it defaults to Regulatory Filings (RNS).
2026-05-29 English
We hereby confirm that the Company has not raised / made offers by way of Public Issue, Rigth Issue, Preferential Issure, Qualified Institutions Placement (QIP), etc. therefore for the ....
Regulatory Filings Classification · 87% confidence The document is a formal regulatory disclosure to the stock exchange regarding the non-applicability of the Statement of Deviation or Variation under SEBI LODR Regulation 32(1) for the quarter ended March 31, 2026. It does not present financial statements, nor is it a management report or investor presentation, but rather a compliance announcement under listing obligations. This fits the description of a general regulatory filing (fallback category).
2026-05-29 English
This is to inform you that disclosures of the Related Party Transaction on a consolidated basis under Regualtion 23(9) of SEBI (LODR) (Amendment) Regualtion 2018 is not applicable to our company..
Regulatory Filings Classification · 85% confidence The document is a letter submitted to the stock exchange under SEBI LODR requirements, certifying non-applicability of certain corporate governance provisions under Regulation 15(2). It does not contain substantive financial statements or an actual report, nor is it a simple announcement of a report’s publication. It is an attestation/certification filed with the regulator, fitting the fallback ‘Regulatory Filings’ category.
2026-05-29 English
This is to inform you that Annual Secretarial Compliance Report Under Regulartion 24A of SEBI (LODR) (Amendment) Regualtion 2018 read with BSE Circular dated 9th May 2019 is not applicable ....
Regulatory Filings Classification · 88% confidence The document is a formal letter to the stock exchange certifying non-applicability of SEBI (LODR) Regulation 24A based on the company’s paid-up capital and net worth. It is an attestation/compliance letter rather than a financial report or announcement of results. It does not contain financial statements or serve as an AGM/annual/interim report. Under the Certification Rule, officer certifications or compliance confirmations are classified as general regulatory filings (RNS).
2026-05-29 English
Audited Financial Results of the Company for the Quarter / Year Ended 31st March 2026 duly Reviewed by the Audi Committee along with Declaration is given in compliance to Regulation 30(3)(d) ....
Interim / Quarterly Report Classification · 85% confidence The document is a formal submission under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 of the company’s audited financial results for the quarter and year ended March 31, 2026. It includes: 1) Board approval letters under Regulation 30 & 33, 2) Declaration under Regulation 33(3)(d), 3) the Independent Auditor’s Report, and 4) the detailed financial results table (quarterly and year-to-date numbers). This is clearly an audited interim/quarterly results filing containing actual financial statements (not just highlights), but it is not the full annual report. It therefore fits the definition of an Interim/Quarterly Report (IR). FY 2026
2026-05-29 English
We would like to inform you that, pursuant to Notice of Board meeting dated 22nd May 2026 the Board Meeting of the Company was held today Friday, 29th May 2026 at 3.00 p.m. at 4th Floor, ....
Regulatory Filings Classification · 75% confidence The document is a set of stock‐exchange disclosures under SEBI (Listing Obligations and Disclosure Requirements) Regulations – the outcome of a Board meeting, approval and submission of audited financial results, and declaration on auditor’s report. It does not contain the full Annual Report or detailed financial statements but rather is an official regulatory announcement to the exchange. Therefore, it best fits the Regulatory Filings category (RNS).
2026-05-29 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.